Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial Article

cited authors

  • Boorjian, Stephen A.; Alemozaffar, Mehrdad; Konety, Badrinath R.; Shore, Neal D.; Gomella, Leonard G.; Kamat, Ashish M.; Bivalacqua, Trinity J.; Montgomery, Jeffrey S.; Lerner, Seth P.; Busby, Joseph E.; Poch, Michael; Crispen, Paul L.; Steinberg, Gary D.; Schuckman, Anne K.; Downs, Tracy M.; Svatek, Robert S.; Mashni, Joseph, Jr.; Lane, Brian R.; Guzzo, Thomas J.; Bratslavsky, Gennady; Karsh, Lawrence I.; Woods, Michael E.; Brown, Gordon; Canter, Daniel; Luchey, Adam; Lotan, Yair; Krupski, Tracey; Inman, Brant A.; Williams, Michael B.; Cookson, Michael S.; Keegan, Kirk A.; Andriole, Gerald L., Jr.; Sankin, Alexander I.; Boyd, Alan; O'Donnell, Michael A.; Sawutz, David; Philipson, Richard; Coll, Ruth; Narayan, Vikram M.; Treasure, F. Peter; Yla-Herttuala, Seppo; Parker, Nigel R.; Dinney, Colin P. N.

Publication Date

  • January 1, 2021

webpage

published in

category

start page

  • 107

end page

  • 117

volume

  • 22

issue

  • 1